optiLIGHT

OptiLIGHT: A Bright Solution for Dry Eyes

If you’re struggling with dry, itchy, red, or burning eyes, you're not alone. Millions of people suffer from dry eye disease, and up to 86% of cases are caused by Meibomian Gland Dysfunction (MGD). At Jeffries Eye Care, we understand how this condition can disrupt your life, and we're here to help with a groundbreaking solution: OptiLIGHT.

The First and Only FDA-Approved Light Therapy for Dry Eye Disease

OptiLIGHT is a cutting-edge treatment specifically designed for dry eye disease caused by MGD. Using Lumenis’ patented Optimal Pulse Technology, this therapy targets inflammation, a key factor contributing to dry eyes. OptiLIGHT is gentle, effective, and non-invasive, providing a comfortable way to treat your symptoms without disrupting your daily routine.

What Makes OptiLIGHT Stand Out?

• FDA-approved light therapy: The first light therapy specifically designed for dry eye disease.
• Targeted treatment: Uses broad-spectrum light to reduce inflammation, improve tear production, and restore comfort.
• Quick and gentle: Each session lasts 10-15 minutes with minimal discomfort.
• Noticeable results: Most patients see improvement after 2-3 sessions.
• Minimal downtime: Some redness may occur but fade within hours, allowing you to resume daily activities.
• Treatment plan: Typically involves 4 sessions, spaced 2-4 weeks apart.
• Long-term relief: Maintenance treatments are recommended every 6-12 months.
• Enhanced results: Often paired with Meibomian Gland expression for maximum effectiveness.

Take Control of Your Dry Eyes Today

Don’t let dry, uncomfortable eyes disrupt your daily life. OptiLIGHT offers a safe and effective way to treat dry eye disease due to MGD and restore comfort to your eyes. Contact Jeffries Eye Care to learn more about OptiLIGHT and how it can provide long-lasting relief.

At Jeffries Eye Care, we’re committed to providing the latest, most effective treatments for eye care. With OptiLIGHT, we offer a fast, gentle solution designed to deliver real results. Call today to schedule your consultation and take the first step toward better eye health.

RISK INFORMATION

Lumenis energy-based treatments are not suitable for everyone and, like every treatment, can carry some risks. Treatment with OptiLIGHT is contraindicated for patients with the following conditions in the treatment area: active infections, dysplastic nevi, tattoos, significant concurrent skin inflammation (excluding rosacea or acne), active cold sores, open lacerations, abrasions, and prolonged sun exposure. Caution is advised for patients with a compromised immune system, coagulation disorders, photosensitivity, hormonal disorders, or a history of Herpes simplex near the treatment area. Patients' eyes must be occluded with eye shields during the treatment. Be sure to consult with your treatment provider to make sure that this treatment is the right choice for you.

SOURCES

1. Kassir et al. (2011) J Cosmet Laser Ther 13(5):216-22; | 2. Papageorgiou et al. (2008) Br J Dermatol 159(3):628-32; | 3. Liu et al. (2017) Am J Ophthalmol 183:81-90.; | 4. Yin et al. (2018) Curr Eye Res 43(3):308-13; | 5. Fishman et al. (2019) Photobiomodul Photomed Laser Surg 38(8):472-6| 6. Lemp MA et al. (2012) Cornea 31(5):472-428; | 7. Toyos et al. (2022) PLoS ONE 17(6)